Hair versus Urine Drug Testing in Forensic Populations: A Systematic Review of Detection Accuracy and Utility
The Saudi Journal of Forensic Medicine and Sciences · مجلد 5 (1) · 36-44
Urine testing is commonly used in forensic and clinical settings, but its short detection window and susceptibility to tampering limit its ability to identify long-term or concealed substance use. In contrast, hair analysis offers a ~90-day retrospective detection window and improved tamper resistance. Following PRISMA 2020 guidelines, we conducted a comprehensive search of PubMed/MEDLINE, Embase, Scopus, Web of Science, and Cochrane from January 2010 to June 2025, including comparative studies that evaluated both hair and urine drug testing in forensic contexts. Twelve studies, published between 2010 and 2023, met the inclusion criteria. The outcomes assessed included positivity rates, detection windows, and context-specific utility. Across most drug classes and settings, hair testing yielded higher positivity rates than urine for chronic or concealed use (e.g., cocaine, stimulants, and opioids), while urine more often detected very recent cannabis/benzodiazepine exposure. In child-protection and prenatal cohorts, hair testing identified exposure patterns that urine missed, with segmental hair testing supporting trimester-specific exposure profiling in perinatal cases. For forensic applications requiring historical exposure records, hair testing should be considered a primary or complementary matrix to urine. The advantages of hair testing include longer detection windows, lower susceptibility to tampering, and better detection of concealed or chronic use, while urine remains useful for detecting recent exposure.
